Category: Halozyme
-
Halozyme wins Dutch injunction against Merck’s Keytruda SC in eight European countries, court holds patent valid
The Hague District Court has upheld Halozyme’s patent and found infringement. Merck’s subcutaneous cancer drug is blocked in eight European countries, but Merck strongly disagrees, alleging the patent is invalid.
-
Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successor
On Thursday, Halozyme obtained a preliminary injunction against Merck’s Keytruda SC.